Fig. 6

In vivo distribution of the nanocomposites. Mice were injected with PBS (A), FITC (B), D/S@MM (C), and D/S@SPMM (D) via tail vein. In vivo imaging was performed on an in vivo imaging system at 1, 4, 8, 12, and 24Â h post-injection
In vivo distribution of the nanocomposites. Mice were injected with PBS (A), FITC (B), D/S@MM (C), and D/S@SPMM (D) via tail vein. In vivo imaging was performed on an in vivo imaging system at 1, 4, 8, 12, and 24Â h post-injection